Cargando…

Rotavirus Vaccine Schedules and Vaccine Response Among Infants in Low- and Middle-Income Countries: A Systematic Review

BACKGROUND: Rotavirus vaccine schedules may impact vaccine response among children in low- and middle-income countries (LMICs). Our objective was to review the literature evaluating the effects of monovalent (RV1) or pentavalent rotavirus vaccines schedules on vaccine response. METHODS: We searched...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gruber, Joann F., Gruber, Lucinda M., Weber, Rachel Palmieri, Becker-Dreps, Sylvia, Jonsson Funk, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445722/ https://www.ncbi.nlm.nih.gov/pubmed/28567431 http://dx.doi.org/10.1093/ofid/ofx066

Ejemplares similares

Patterns of Rotavirus Vaccine Uptake and Use in Privately-Insured US Infants, 2006–2010
por: Panozzo, Catherine A., et al.
Publicado: (2013)

Rotavirus vaccine protection in low-income and middle-income countries
por: Ramakrishnan, Girija, et al.
Publicado: (2019)

Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants
por: Chilengi, Roma, et al.
Publicado: (2016)

Update on rotavirus vaccine underperformance in low- to middle-income countries and next-generation vaccines
por: Lee, Benjamin
Publicado: (2020)

Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules
por: Clark, Andrew, et al.
Publicado: (2019)

Systematic Review and Meta-Analysis of Cost-effectiveness of Rotavirus Vaccine in Low-Income and Lower-Middle-Income Countries
por: Haider, Sabbir, et al.
Publicado: (2019)

Balancing safety, efficacy and cost: Improving rotavirus vaccine adoption in low- and middle-income countries
por: Bhan, Anant, et al.
Publicado: (2011)

Measuring indirect effects of rotavirus vaccine in low income countries
por: Bennett, Aisleen, et al.
Publicado: (2016)

Healthcare provider perspectives on delivering next generation rotavirus vaccines in five low-to-middle-income countries
por: Mooney, Jessica, et al.
Publicado: (2022)

Changes in Pneumonia Incidence and Infant Mortality 5 Years Following Introduction of the 13-valent Pneumococcal Conjugate Vaccine in a “3+0” Schedule in Nicaragua
por: Becker-Dreps, Sylvia, et al.
Publicado: (2017)

Changes in the incidence of pneumonia, bacterial meningitis, and infant mortality 5 years following introduction of the 13-valent pneumococcal conjugate vaccine in a "3+0" schedule
por: Becker-Dreps, Sylvia, et al.
Publicado: (2017)

Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries
por: Boujaoude, Marie-Anne, et al.
Publicado: (2018)

Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries
por: Gallagher, Katherine E., et al.
Publicado: (2018)

Trends in vaccine investment in middle income countries
por: Onishchenko, K., et al.
Publicado: (2019)

Improving childhood vaccination in low-income and middle-income countries
por: eBioMedicine
Publicado: (2023)

Impact of rotavirus vaccine on diarrheal hospitalization and outpatient consultations in the Philippines: First evidence from a middle-income Asian country
por: Lopez, Anna Lena, et al.
Publicado: (2018)

Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study
por: Riumallo-Herl, Carlos, et al.
Publicado: (2018)

Defining the Recipe for an Optimal Rotavirus Vaccine Introduction in a High-Income Country in Europe
por: Standaert, Baudouin, et al.
Publicado: (2022)

The Economic Value of Rotavirus Vaccination When Optimally Implemented in a High-Income Country
por: Standaert, Baudouin
Publicado: (2023)

Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?
por: Steele, A.D., et al.
Publicado: (2019)

Pneumococcal conjugate vaccine implementation in middle-income countries
por: Tricarico, Serena, et al.
Publicado: (2017)

Vaccine manufacturing capacity in low- and middle-income countries
por: Khan, Mohammed Imran, et al.
Publicado: (2021)

Rotavirus vaccination and intussusception – Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries
por: Yen, Catherine, et al.
Publicado: (2016)

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2021)

Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries
por: Kumar, Prashant, et al.
Publicado: (2021)

A systematic review and meta-analysis of the effects of educating parents on the benefits and schedules of childhood vaccinations in low and middle-income countries
por: Lukusa, Lungeni Auguy, et al.
Publicado: (2018)

Lessons Learned from Long-Term Assessment of Rotavirus Vaccination in a High-Income Country: The Case of the Rotavirus Vaccine Belgium Impact Study (RotaBIS)
por: Standaert, Baudouin, et al.
Publicado: (2020)

Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines
por: Chandran, Aruna, et al.
Publicado: (2010)

Transporting monovalent rotavirus vaccine efficacy estimates to an external target population: a secondary analysis of data from a randomised controlled trial in Malawi
por: St Jean, Denise T., et al.
Publicado: (2023)

Systematic review of the costs and effectiveness of interventions to increase infant vaccination coverage in low- and middle-income countries
por: Munk, Cristina, et al.
Publicado: (2019)

Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule
por: Geard, Nicholas, et al.
Publicado: (2022)

Rotaviruses and Rotavirus Vaccines
por: Donato, Celeste M., et al.
Publicado: (2021)

Vaccination schedule for infants and COVID-19
Publicado: (2020)

Childhood vaccines and antibiotic use in low- and middle-income countries
por: Lewnard, Joseph A., et al.
Publicado: (2020)

Mapping routine measles vaccination in low- and middle-income countries
Publicado: (2020)

Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics
Publicado: (2021)

COVID-19 vaccines pricing policy options for low-income and middle- income countries
por: Guzman, Javier, et al.
Publicado: (2021)

A Randomized, Controlled Trial of the Impact of Alternative Dosing Schedules on the Immune Response to Human Rotavirus Vaccine in Rural Ghanaian Infants
por: Armah, George, et al.
Publicado: (2016)

Effect of Pneumococcal Conjugate Vaccination in Uruguay, a Middle-Income Country
por: García Gabarrot, Gabriela, et al.
Publicado: (2014)

Issues in pediatric vaccine-preventable diseases in low- to middle-income countries
por: Dbaibo, Ghassan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7tfr2ci8u5ue8mgo1n64fs2sld